X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1162) 1162
male (726) 726
index medicus (648) 648
pyrimidinones - pharmacology (619) 619
female (543) 543
animals (527) 527
pyrimidinones - therapeutic use (458) 458
adult (437) 437
lopinavir (417) 417
pharmacology & pharmacy (340) 340
middle aged (315) 315
pyrimidinones - administration & dosage (310) 310
hiv infections - drug therapy (307) 307
pyrimidinones - pharmacokinetics (248) 248
mice (228) 228
infectious diseases (226) 226
pyrimidinones - adverse effects (207) 207
pyrimidinones - blood (198) 198
rats (194) 194
pyrimidinones - chemistry (182) 182
ritonavir - therapeutic use (176) 176
treatment outcome (173) 173
ritonavir (163) 163
drug therapy, combination (157) 157
aged (155) 155
immunology (152) 152
biochemistry & molecular biology (149) 149
pharmacokinetics (138) 138
hiv (136) 136
hiv protease inhibitors - therapeutic use (134) 134
dose-response relationship, drug (132) 132
ritonavir - administration & dosage (129) 129
protease inhibitors (119) 119
viral load (117) 117
virology (117) 117
therapy (112) 112
hiv infections - virology (106) 106
oncology (105) 105
anti-hiv agents - therapeutic use (104) 104
drug therapy (102) 102
research (101) 101
thymidine - analogs & derivatives (101) 101
antiviral agents (98) 98
pyrimidinones - chemical synthesis (98) 98
chemistry, medicinal (96) 96
analysis (94) 94
rna, viral - blood (94) 94
hiv protease inhibitors - administration & dosage (91) 91
hiv-1 - drug effects (91) 91
structure-activity relationship (91) 91
administration, oral (88) 88
health aspects (88) 88
hiv infections - blood (88) 88
ritonavir - adverse effects (88) 88
adolescent (85) 85
hepatitis b, chronic - drug therapy (85) 85
pyrimidinones (85) 85
pyrimidinones - metabolism (83) 83
mutation (82) 82
article (80) 80
cancer (80) 80
hiv protease inhibitors - pharmacokinetics (80) 80
ritonavir - pharmacokinetics (80) 80
antiretroviral therapy (79) 79
drug administration schedule (79) 79
lopinavir/ritonavir (78) 78
microbiology (78) 78
nucleosides - therapeutic use (78) 78
antiviral agents - therapeutic use (77) 77
care and treatment (77) 77
hiv-1 (75) 75
cell line, tumor (74) 74
time factors (74) 74
hiv protease inhibitors - blood (73) 73
young adult (73) 73
hiv protease inhibitors - adverse effects (72) 72
cd4 lymphocyte count (71) 71
ritonavir - blood (71) 71
hematology (70) 70
lamivudine (69) 69
rats, sprague-dawley (68) 68
dogs (67) 67
anti-hiv agents - administration & dosage (66) 66
kinetics (66) 66
drug interactions (65) 65
biophysics (64) 64
in vitro techniques (64) 64
prospective studies (64) 64
drug combinations (63) 63
antiretroviral therapy, highly active (62) 62
cells, cultured (61) 61
lamivudine - therapeutic use (61) 61
resistance (61) 61
apoptosis (60) 60
area under curve (60) 60
anti-hiv agents - adverse effects (59) 59
antineoplastic agents - pharmacology (59) 59
disease models, animal (59) 59
hiv infection (59) 59
cell biology (58) 58
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1471) 1471
Chinese (18) 18
German (10) 10
Japanese (8) 8
Spanish (7) 7
French (4) 4
Russian (2) 2
Italian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


AIDS, ISSN 0269-9370, 09/2007, Volume 21, Issue 14, pp. 1899 - 1907
Objectives: To describe first dose and steady state antiretroviral drug exposure in the female genital tract. Design: Non-blinded, single center, open-label... 
Women | Genital tract | HIV | Prophylaxis | Sexual transmission | Pharmacokinetics | Antiretroviral therapy | genital tract | INFECTIOUS DISEASES | sexual transmission | antiretroviral therapy | EMTRICITABINE | IMMUNOLOGY | CEREBROSPINAL-FLUID | prophylaxis | BACTERIAL VAGINOSIS | PROTEASE INHIBITOR | TRICHOMONAS-VAGINALIS | HIV-INFECTION | THERAPY | VIROLOGY | LIQUID-CHROMATOGRAPHY | SIMIAN IMMUNODEFICIENCY VIRUS | pharmacokinetics | MACAQUES | women | Lamivudine - administration & dosage | Humans | Deoxycytidine - blood | Zidovudine - administration & dosage | Tenofovir | Deoxycytidine - pharmacokinetics | HIV Protease Inhibitors - pharmacokinetics | Atazanavir Sulfate | Genitalia, Female - metabolism | Emtricitabine | HIV Infections - blood | HIV Protease Inhibitors - blood | Adenine - analogs & derivatives | Pyridines - administration & dosage | Benzoxazines - administration & dosage | Administration, Oral | Anti-Retroviral Agents - pharmacokinetics | Deoxycytidine - administration & dosage | Lopinavir | HIV Protease Inhibitors - administration & dosage | Adenine - pharmacokinetics | Pyrimidinones - blood | Anti-Retroviral Agents - administration & dosage | Oligopeptides - administration & dosage | Pyrimidinones - administration & dosage | Zidovudine - blood | Deoxycytidine - analogs & derivatives | Reverse Transcriptase Inhibitors - blood | Zidovudine - pharmacokinetics | Pyridines - pharmacokinetics | Reverse Transcriptase Inhibitors - administration & dosage | Adenine - blood | Reverse Transcriptase Inhibitors - pharmacokinetics | Benzoxazines - pharmacokinetics | Adult | Benzoxazines - blood | Female | Organophosphonates - blood | Anti-Retroviral Agents - blood | Drug Therapy, Combination | Oligopeptides - blood | Oligopeptides - pharmacokinetics | Lamivudine - blood | Lamivudine - pharmacokinetics | Adenine - administration & dosage | Organophosphonates - pharmacokinetics | Organophosphonates - administration & dosage | Pyridines - blood | Pyrimidinones - pharmacokinetics | HIV Infections - drug therapy
Journal Article
Clinica Chimica Acta, ISSN 0009-8981, 07/2017, Volume 470, pp. 8 - 13
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 4, pp. 482 - 489
Journal Article
Journal Article
Journal Article
Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, 2007, Volume 43, Issue 4, pp. 1562 - 1567
An accurate, sensitive and simple reverse-phase (RP) high-performance liquid chromatography (HPLC) assay has been developed and validated for the simultaneous... 
Therapeutic drug monitoring | High-performance liquid chromatography (HPLC) | Tipranavir | Antiretroviral drug | Protease inhibitor | CHEMISTRY, ANALYTICAL | antiretroviral drug | protease inhibitor | REVERSE-TRANSCRIPTASE INHIBITORS | tipranavir | QUANTIFICATION | PHARMACOLOGY & PHARMACY | UV DETECTION | ATAZANAVIR | high-performance liquid chromatography (HPLC) | therapeutic drug monitoring | RITONAVIR | Saquinavir - blood | Nelfinavir - chemistry | Chromatography, High Pressure Liquid - methods | Pyridines - chemistry | Humans | Benzoxazines | Carbamates - chemistry | Pyrimidinones - chemistry | Indinavir - chemistry | Pyrones - blood | Nevirapine - blood | Sulfonamides - blood | Indinavir - blood | Pyrones - chemistry | Time Factors | Sensitivity and Specificity | Atazanavir Sulfate | Molecular Structure | Anti-HIV Agents - blood | Oligopeptides - chemistry | HIV Protease Inhibitors - blood | Reproducibility of Results | Saquinavir - chemistry | Oligopeptides - blood | Sulfonamides - chemistry | Ritonavir - blood | Drug Stability | Lopinavir | Carbamates - blood | HIV Protease Inhibitors - chemistry | Spectrophotometry, Ultraviolet | Nelfinavir - blood | Ritonavir - chemistry | Anti-HIV Agents - chemistry | Pyridines - blood | Nevirapine - chemistry | Pyrimidinones - blood | Oxazines - chemistry | Oxazines - blood | Antiviral agents | Highly active antiretroviral therapy | Liquid chromatography | Anti-HIV agents
Journal Article
Cancer, ISSN 0008-543X, 06/2016, Volume 122, Issue 12, pp. 1871 - 1879
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 4/2007, Volume 195, Issue 7, pp. 973 - 979
Background. Most antiretrovirals are metabolized in the liver, and lower dosing could be advisable in patients with severe liver insufficiency. Methods. Plasma... 
HIV/AIDS | Cirrhosis | Antiretrovirals | Liver diseases | Liver | Chronic hepatitis | Fibrosis | Antivirals | AIDS | Pharmacokinetics | Blood plasma | TRANSIENT ELASTOGRAPHY | DIAGNOSIS | INFECTIOUS DISEASES | REVERSE-TRANSCRIPTASE INHIBITORS | COINFECTED SUBJECTS | METABOLISM | DISEASE | HEPATOTOXICITY | HUMAN-IMMUNODEFICIENCY-VIRUS | NEVIRAPINE | PROTEASE INHIBITORS | Hepatitis C, Chronic - pathology | Humans | Male | Nevirapine - therapeutic use | Benzoxazines | Oligopeptides - therapeutic use | Anti-HIV Agents - administration & dosage | Nevirapine - blood | Atazanavir Sulfate | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Oxazines - administration & dosage | Anti-HIV Agents - blood | Pyridines - therapeutic use | Severity of Illness Index | Pyridines - administration & dosage | Oligopeptides - blood | Ritonavir - administration & dosage | Ritonavir - blood | Lopinavir | Pyrimidinones - therapeutic use | Hepatitis C, Chronic - blood | Pyridines - blood | Pyrimidinones - blood | Oxazines - therapeutic use | Liver Cirrhosis - pathology | HIV Infections - drug therapy | Oligopeptides - administration & dosage | Pyrimidinones - administration & dosage | Drug Monitoring | Nevirapine - administration & dosage | Oxazines - blood | Antiviral agents | Analysis | Physiological aspects | Plasma cells | Drug metabolism | Cystic fibrosis | Influence | HIV patients | Research | Hepatitis C
Journal Article
AIDS, ISSN 0269-9370, 10/2006, Volume 20, Issue 15, pp. 1931 - 1939
Journal Article
Gastroenterology, ISSN 0016-5085, 2009, Volume 136, Issue 2, pp. 486 - 495
Background & Aims The GLOBE trial has compared the efficacy and safety of telbivudine versus lamivudine treatment over 2 years in patients with chronic... 
Gastroenterology and Hepatology | VIRAL LOAD | E-ANTIGEN | ENTECAVIR | THERAPY | VIRUS | POSITIVE CHRONIC HEPATITIS | ADEFOVIR DIPIVOXIL | RISK | NATURAL-HISTORY | YMDD VARIANTS | GASTROENTEROLOGY & HEPATOLOGY | Prospective Studies | Humans | Middle Aged | Male | Alanine Transaminase - blood | Hepatitis B Surface Antigens - blood | Lamivudine - adverse effects | Young Adult | Lamivudine - therapeutic use | Nucleosides - pharmacology | Adult | Female | Hepatitis B, Chronic - blood | Pyrimidinones - pharmacology | Hepatitis B virus - immunology | Nucleosides - therapeutic use | Virus Replication - drug effects | Antiviral Agents - pharmacology | DNA, Viral - drug effects | Double-Blind Method | Global Health | Antiviral Agents - therapeutic use | Pyrimidinones - adverse effects | Pyrimidinones - therapeutic use | Treatment Outcome | Nucleosides - adverse effects | Regression Analysis | Hepatitis B, Chronic - drug therapy | Thymidine - analogs & derivatives | Antiviral Agents - adverse effects | Adolescent | Hepatitis B virus - genetics | Aged | Lamivudine - pharmacology | Hepatitis B e Antigens - blood | Longitudinal Studies | Polymerase chain reaction | Care and treatment | Creatine kinase | Analysis | Gastrointestinal diseases | Clinical trials | Lamivudine | Creatine | Hepatitis B | Index Medicus | Abridged Index Medicus
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2009, Volume 49, Issue 9, pp. 1305 - 1311
Journal Article
Therapeutic Drug Monitoring, ISSN 0163-4356, 04/2005, Volume 27, Issue 2, pp. 186 - 192
Several studies suggest that therapeutic drug monitoring of protease inhibitors and nonnucleoside reverse transcriptase inhibitors may contribute to the... 
Therapeutic drug monitoring | High-performance liquid chromatography | Nonnucleoside reverse transcriptase inhibitors | HIV protease inhibitors | ASSAY | normucleoside reverse transcriptase inhibitors | high-performance liquid chromatography | PHARMACOLOGY & PHARMACY | TOXICOLOGY | MEDICAL LABORATORY TECHNOLOGY | TANDEM MASS-SPECTROMETRY | therapeutic drug monitoring | BLOOD MONONUCLEAR-CELLS | BMS-232632 | QUANTITATIVE-DETERMINATION | Saquinavir - blood | Reverse Transcriptase Inhibitors - blood | Humans | Nevirapine - therapeutic use | Benzoxazines | Saquinavir - therapeutic use | Oligopeptides - therapeutic use | Nevirapine - blood | Sulfonamides - blood | HIV Protease Inhibitors - classification | Indinavir - blood | Atazanavir Sulfate | Ritonavir - therapeutic use | Chromatography, Liquid - trends | Reverse Transcriptase Inhibitors - therapeutic use | Pyridines - therapeutic use | HIV Protease Inhibitors - blood | Nelfinavir - therapeutic use | Reproducibility of Results | Oligopeptides - blood | Ritonavir - blood | Drug Stability | Lopinavir | Pyrimidinones - therapeutic use | Specimen Handling - methods | Calibration - standards | HIV Protease Inhibitors - therapeutic use | Nelfinavir - blood | Pyridines - blood | Pyrimidinones - blood | Sulfonamides - therapeutic use | Oxazines - therapeutic use | Spectrophotometry, Ultraviolet - methods | Carbamates | HIV Infections - drug therapy | Chromatography, Liquid - methods | Oxazines - blood | Indinavir - therapeutic use
Journal Article
Biochemistry (Moscow), ISSN 0006-2979, 7/2016, Volume 81, Issue 7, pp. 691 - 699
Journal Article